NTRK, ROS1, and ALK Rearrangements in Sarcoma
Sarcoma refers to a malignant tumor that develops from bone or soft tissues like fat and muscle.
- An estimated 2% to 7% of patients diagnosed with Sarcoma have NTRK gene rearrangements.
- Gene rearrangements in ROS1 or ALK have also been identified in sarcoma biopsy samples.
See if you or a loved one may be eligible for the study.